Athira Pharma Inc

+0.34 (+1.92%)
Earnings Announcements

Athira Pharma Reports Q4 Loss Per Share Of $0.24

Published: 03/25/2021 21:44 GMT
Athira Pharma Inc (ATHA) - Athira Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights.
Q4 Loss per Share $0.24.
Q4 Earnings per Share Estimate $-0.40 -- Refinitiv Ibes Data (analyst estimates).
Cash, Cash Equivalents and Marketable Securities Were $268.2 Million As of December 31, 2020.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.30

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.34

More details on our Analysts Page.